Isap 1000 Capsule contains Icosapent ethyl 1000 mg, a purified ethyl ester of eicosapentaenoic acid (EPA), an omega-3 fatty acid primarily used as an adjunctive therapy to reduce elevated triglyceride levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL). Icosapent ethyl works by decreasing hepatic triglyceride synthesis and enhancing triglyceride clearance, thereby lowering plasma triglyceride concentrations. It is indicated for patients who have not achieved adequate triglyceride control through diet and lifestyle modifications alone. Clinical studies have demonstrated that Isap 1000 Capsule effectively reduces triglycerides without significantly increasing low-density lipoprotein cholesterol (LDL-C), a common concern with other lipid-lowering agents. The medication is generally well-tolerated, with a safety profile consistent with omega-3 fatty acid therapies; common adverse effects may include gastrointestinal discomfort such as dyspepsia, nausea, and diarrhea. Isap 1000 Capsule should be administered under medical supervision, with dosing tailored to individual patient needs, typically 2 grams twice daily with meals. It is contraindicated in patients with known hypersensitivity to fish or shellfish products. Regular monitoring of lipid levels and liver function tests is recommended during therapy to ensure efficacy and safety.